3 minNew era in nasopharyngeal cancer: Toripalimab opens doors for immunotherapy.For decades, nasopharyngeal cancer patients facing recurrent or metastatic disease had limited treatment options.
4 minHope on the horizon: TAK-500 takes aim at nasopharyngeal cancer.Nasopharyngeal cancer (NPC) is a rare form of cancer that originates in the upper part of the throat behind the nose, known as the nasophary
3 minDeferred surgery for kidney cancer: A viable option in the age of improved systemic therapies?Newer targeted therapies and immunotherapies approved over the last decade can effectively manage metastatic kidney cancer on their own.
4 minImmunotherapy triumphs in kidney cancer: A comparative lookKidney cancer is a type of cancer that occurs when the cells in the kidney multiply rapidly and uncontrollably.
4 minAntibody-drug conjugates in the treatment of uterine cancers: A promising therapeutic approachUterine cancers, which largely comprise endometrial cancer and uterine sarcoma, are a considerable health concern affecting women worldwide.